- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03956004
The Impact of a Technology-enabled Decision Aid, for Patients With Hip and Knee Osteoarthritis on Decision Quality, Level of Shared Decision-making, Patient Satisfaction and Magnitude of Limitations
August 14, 2020 updated by: Kevin Bozic, University of Texas at Austin
A Technology-enabled Decision Aid for Patients With Hip and Knee Osteoarthritis
This study evaluates a technology-enabled decision aid that provides evidence-based education (i.e. on understanding the condition, treatment options and comparisons, patient values and question & answer quiz) and personalized, quantifiable benefit-risk ratio alongside the level of potential benefit in relation to joint stiffness, joint pain and quality of life.
The study will be performed in the setting of an integrated care system providing patient-centered care for hip and knee osteoarthritis over the full cycle of care.
The impact of a technology-enabled decision aid incorporating predictive analytics with machine learning capabilities on decision quality, activation, experience & limitations of patients in this setting is relatively unknown.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
145
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Austin, Texas, United States, 78712
- UT Health Austin
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years to 89 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- All patients with a presumptive diagnosis of knee OA aged between 45 and 89 (in-line with the decision aid algorithm)
- Radiographic evidence of moderate to severe osteoarthritis (Kellgren and Lawrence grade 3-4)
- KOOS Jr scores between 0-85 (in-line with the decision-aid algorithm)
- Participant able to give informed consent for participation in the study
Exclusion Criteria:
- Kellgren and Lawrence scale for classification of osteoarthritis grade 0-2
- Patients with a prior experience of total joint replacement
- Patient with experience with the pilot form of the decision aid
- Patients undergoing consideration for revision joint replacement
- Patients seeking care for trauma condition or psoriatic/rheumatoid arthritis
- Non-English or Non-Spanish speakers
- Patients with BMI below 20 or above 46 (in-line with the decision-aid algorithm)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental
Full decision aid, consisting of education on osteoarthritis and treatment options, preferences and values elicitation, and personalized risk/benefit estimates based on patient's response to patient-reported outcome measures.
|
Decision aid meant to improve shared decision making among patients and providers.
|
Active Comparator: Control
Education component of the decision aid only.
|
Investigator-written educational material and quiz to test knowledge of osteoarthritis and treatment options.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Knee Osteoarthritis Decision Quality Instrument
Time Frame: Day 1
|
Decision process subscore.
Participants receive 1 point for a response of "yes" or "a lot/some."
The total points are summed and then divided by the total number of items to result in scores from 0-100%, with higher scores indicated a more shared decision making process.
|
Day 1
|
Knee Osteoarthritis Decision Quality Instrument
Time Frame: Day 1
|
Concordance subscore (A summary score (0-100%) indicating the percentage of patients who received treatment that matched their stated preference will be generated.)
|
Day 1
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
CollaboRATE
Time Frame: Day 1
|
Level of shared decision making.
Range of 0-9.
Higher scores represent more shared decision making.
|
Day 1
|
Numeric rating scale-satisfaction
Time Frame: Day 1
|
Patient satisfaction with management of condition.
Range of 0-10 with 0 representing complete dissatisfaction and 10 representing complete satisfaction.
|
Day 1
|
Knee injury and osteoarthritis outcome score, joint replacement (KOOS JR)
Time Frame: 6 months after baseline visit
|
Measure of patient-reported, knee-related stiffness, pain, and function.
Raw score range 0-28, converted to interval score of 0-100, where 0 represents total knee disability and 100 represents perfect knee health.
|
6 months after baseline visit
|
Undergoing joint replacement surgery or not
Time Frame: Day 1
|
Decision to undergo total knee replacement surgery (yes/no).
Obtained by asking provider or through medical record note.
|
Day 1
|
Average time of patient visit and average time spent with provider
Time Frame: Day 1
|
Minutes.
Time of entire visit will be recorded in addition to time spent with primary provider.
|
Day 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Kevin Bozic, Dell Medical School at The University of Texas at Austin
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 28, 2019
Primary Completion (Actual)
January 30, 2020
Study Completion (Actual)
January 30, 2020
Study Registration Dates
First Submitted
March 25, 2019
First Submitted That Met QC Criteria
May 17, 2019
First Posted (Actual)
May 20, 2019
Study Record Updates
Last Update Posted (Actual)
August 17, 2020
Last Update Submitted That Met QC Criteria
August 14, 2020
Last Verified
August 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2018-11-0042
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarthritis, Knee
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
University Hospital, Clermont-FerrandSanofiCompletedKnee Osteoarthritis (Knee OA)France
-
Joseph E. BroylesCompletedDegenerative Lesion of Articular Cartilage of Knee | Degeneration; Articular Cartilage, Knee | Unilateral Primary Osteoarthritis of Knee | Osteoarthritis Knee
-
The Hong Kong Polytechnic UniversityCompleted
-
Federal University of São PauloCompletedKNEE OSTEOARTHRITISBrazil
-
Jiangsu XinChen-Techfields Pharma Co., LTD.Completed
-
Thammasat UniversityCompletedPrimary Knee OsteoarthritisThailand
-
Galderma R&DCompletedUnilateral Knee OsteoarthritisUnited Kingdom
-
National Yang Ming UniversityFar Eastern Memorial HospitalCompletedMedial Knee OsteoarthritisTaiwan
-
Hanlim Pharm. Co., Ltd.CompletedKnee OsteoarthritisKorea, Republic of
Clinical Trials on OM1 Dell Shared Decision Making Tool
-
Hospital for Special Surgery, New YorkJohns Hopkins University; Baylor College of Medicine; University of Pennsylvania and other collaboratorsTerminatedKnee OsteoarthritisUnited States
-
Columbia UniversityNational Institute of Nursing Research (NINR)RecruitingAtrial Fibrillation | Patient EngagementUnited States
-
University College, LondonUnknown
-
Taipei Medical UniversityUnknownShared Decision Making | Self-Efficacy for Decision MakingTaiwan
-
Taipei Medical UniversityCompletedShared Decision Making | Quality of Care | Patient Decision Aids | Evidence-based Medicine | Lumbar Degenerative DiseaseTaiwan
-
Queen's University, BelfastNorthern Ireland Chest Heart and StrokeCompleted
-
Mackay Medical CollegeTaipei Veterans General Hospital, TaiwanCompletedBreast Neoplasm Female
-
Centers for Disease Control and PreventionUnknown
-
Columbia UniversityNational Heart, Lung, and Blood Institute (NHLBI)RecruitingDepressive Symptoms | Coronary Heart DiseaseUnited States
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLCRecruiting